API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
Impressions: 2663
https://www.pharmacompass.com/radio-compass-blog/america-s-drug-price-hike-conundrum-in-backdrop-of-2019-medicare-part-d-data
Impressions: 55099
https://www.pharmacompass.com/radio-compass-blog/top-drugs-and-pharmaceutical-companies-of-2019-by-revenues
Impressions: 8296
https://www.pharmacompass.com/radio-compass-blog/dmf-submissions-in-2019-india-maintains-bulk-drug-supply-supremacy-to-us
Impressions: 58839
https://www.pharmacompass.com/radio-compass-blog/top-drugs-by-sales-in-2017-who-sold-the-blockbuster-drugs
Impressions: 2580
https://www.pharmacompass.com/radio-compass-blog/fda-announces-generic-drug-user-fees-for-fy18-gilead-acquires-kite-for-us-12-billion
Impressions: 5969
https://www.pharmacompass.com/radio-compass-blog/india-leads-dmf-submissions-to-the-fda-during-q4-of-2016-and-q1-of-2017
Impressions: 9364
https://www.pharmacompass.com/radio-compass-blog/chemical-entities-shine-in-the-top-10-fastest-growing-drugs-of-2016
Impressions: 3239
https://www.pharmacompass.com/radio-compass-blog/does-the-fda-promote-european-manufacturers-over-others-the-ice-bucket-challenge-winner
Impressions: 5640
https://www.pharmacompass.com/radio-compass-blog/teva-ceo-steps-down-fda-warning-letters-to-firms-in-japan-india-china
Impressions: 2098
https://www.pharmacompass.com/radio-compass-blog/record-fine-levied-on-pfizer-for-hiking-drug-price-us-senate-clears-biggest-drug-approval-reform
Impressions: 57120
https://www.pharmacompass.com/radio-compass-blog/top-drugs-by-sales-revenue-in-2015-who-sold-the-biggest-blockbuster-drugs
Impressions: 8841
https://www.pharmacompass.com/radio-compass-blog/the-next-generic-attack-brilinta-ticagrelor-xarelto-rivaroxaban-tradjenta-linagliptin-and
Impressions: 12833
https://www.pharmacompass.com/radio-compass-blog/who-has-the-biggest-one-sales-of-the-top-pharma-products-by-revenue
Impressions: 5078
https://www.pharmacompass.com/radio-compass-blog/fondaparinux-an-opportunity-worth-developing